$PCRX
Pacira Biosciences Inc

2021 Q1 Form 10-Q Financial Statement

#000139681421000031 Filed on May 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $119.0M $105.7M
YoY Change 12.63% 15.74%
Cost Of Revenue $31.35M $29.73M
YoY Change 5.44% 8.9%
Gross Profit $87.68M $75.95M
YoY Change 15.44% 18.66%
Gross Profit Margin 73.66% 71.87%
Selling, General & Admin $48.52M $44.78M
YoY Change 8.36% -5.34%
% of Gross Profit 55.34% 58.96%
Research & Development $15.88M $15.82M
YoY Change 0.38% 9.98%
% of Gross Profit 18.11% 20.83%
Depreciation & Amortization $4.851M $4.821M
YoY Change 0.62% 33.92%
% of Gross Profit 5.53% 6.35%
Operating Expenses $64.40M $60.60M
YoY Change 6.27% -32.84%
Operating Profit $19.44M $17.09M
YoY Change 13.71% 1484.24%
Interest Expense $6.971M $6.022M
YoY Change 15.76% 3.58%
% of Operating Profit 35.86% 35.23%
Other Income/Expense, Net -$6.713M -$8.537M
YoY Change -21.37% 137.34%
Pretax Income $12.72M $8.557M
YoY Change 48.7% -439.83%
Income Tax $2.400M $400.0K
% Of Pretax Income 18.86% 4.67%
Net Earnings $10.37M $8.159M
YoY Change 27.09% -394.44%
Net Earnings / Revenue 8.71% 7.72%
Basic Earnings Per Share $0.24 $0.19
Diluted Earnings Per Share $0.23 $0.19
COMMON SHARES
Basic Shares Outstanding 43.83M shares 42.03M shares
Diluted Shares Outstanding 45.97M shares 42.79M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $590.1M $318.5M
YoY Change 85.27% -22.77%
Cash & Equivalents $66.70M $54.59M
Short-Term Investments $523.4M $263.9M
Other Short-Term Assets $13.00M $14.50M
YoY Change -10.34% 54.26%
Inventory $64.61M $59.67M
Prepaid Expenses
Receivables $52.58M $38.99M
Other Receivables $0.00 $0.00
Total Short-Term Assets $720.2M $431.6M
YoY Change 66.88% -15.15%
LONG-TERM ASSETS
Property, Plant & Equipment $144.8M $108.1M
YoY Change 33.96% 0.98%
Goodwill $99.50M $99.50M
YoY Change 0.0% 60.48%
Intangibles $94.55M $102.4M
YoY Change -7.68%
Long-Term Investments $51.00M $42.10M
YoY Change 21.14% 198.58%
Other Assets $104.5M
YoY Change
Total Long-Term Assets $567.3M $389.8M
YoY Change 45.54% 85.19%
TOTAL ASSETS
Total Short-Term Assets $720.2M $431.6M
Total Long-Term Assets $567.3M $389.8M
Total Assets $1.288B $821.4M
YoY Change 56.75% 14.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.110M $15.85M
YoY Change -42.52% 18.56%
Accrued Expenses $50.24M $44.72M
YoY Change 12.35% 12.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $151.6M
YoY Change
Total Short-Term Liabilities $232.1M $80.31M
YoY Change 188.97% 36.14%
LONG-TERM LIABILITIES
Long-Term Debt $317.3M $310.1M
YoY Change 2.32% 5.33%
Other Long-Term Liabilities $5.288M $1.535M
YoY Change 244.5% -82.93%
Total Long-Term Liabilities $5.288M $1.535M
YoY Change 244.5% -82.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $232.1M $80.31M
Total Long-Term Liabilities $5.288M $1.535M
Total Liabilities $636.7M $447.3M
YoY Change 42.34% 14.22%
SHAREHOLDERS EQUITY
Retained Earnings -$243.5M -$391.2M
YoY Change -37.76% 0.02%
Common Stock $44.00K $42.00K
YoY Change 4.76% 2.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $650.8M $374.0M
YoY Change
Total Liabilities & Shareholders Equity $1.288B $821.4M
YoY Change 56.75% 14.21%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $10.37M $8.159M
YoY Change 27.09% -394.44%
Depreciation, Depletion And Amortization $4.851M $4.821M
YoY Change 0.62% 33.92%
Cash From Operating Activities $12.08M $6.208M
YoY Change 94.6% 77.42%
INVESTING ACTIVITIES
Capital Expenditures $13.07M $6.724M
YoY Change 94.42% 233.2%
Acquisitions
YoY Change
Other Investing Activities -$42.59M -$21.84M
YoY Change 95.01% -127.13%
Cash From Investing Activities -$55.66M -$28.57M
YoY Change 94.86% -136.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $10.33M -$1.281M
YoY Change -906.01% -341.7%
NET CHANGE
Cash From Operating Activities $12.08M $6.208M
Cash From Investing Activities -$55.66M -$28.57M
Cash From Financing Activities $10.33M -$1.281M
Net Change In Cash -$33.26M -$23.64M
YoY Change 40.69% -128.65%
FREE CASH FLOW
Cash From Operating Activities $12.08M $6.208M
Capital Expenditures $13.07M $6.724M
Free Cash Flow -$992.0K -$516.0K
YoY Change 92.25% -134.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2021Q1 dei Trading Symbol
TradingSymbol
PCRX
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
254-3560
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001396814
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-35060
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
PACIRA BIOSCIENCES, INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
51-0619477
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
5 Sylvan Way, Suite 300
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Parsippany
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07054
CY2021Q1 dei City Area Code
CityAreaCode
973
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44025456 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66699000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99957000 USD
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
523364000 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
421705000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
52583000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53046000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
64606000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
64650000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12995000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12265000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
720247000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
651623000 USD
CY2021Q1 us-gaap Long Term Investments
LongTermInvestments
34971000 USD
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
95459000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
144822000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
136688000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
72888000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
74492000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
99547000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
99547000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
94554000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
96521000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
104467000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
106164000 USD
CY2021Q1 pcrx Equity Method Investments And Other Assets
EquityMethodInvestmentsAndOtherAssets
16053000 USD
CY2020Q4 pcrx Equity Method Investments And Other Assets
EquityMethodInvestmentsAndOtherAssets
14019000 USD
CY2021Q1 us-gaap Assets
Assets
1287549000 USD
CY2020Q4 us-gaap Assets
Assets
1274513000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
9110000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10431000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50239000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
70974000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5503000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7425000 USD
CY2021Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
151647000 USD
CY2020Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
149648000 USD
CY2021Q1 pcrx Contingent Consideration Current
ContingentConsiderationCurrent
14864000 USD
CY2020Q4 pcrx Contingent Consideration Current
ContingentConsiderationCurrent
14736000 USD
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
721000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
114000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
232084000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
253328000 USD
CY2021Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
317338000 USD
CY2020Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
313030000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
69666000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
71025000 USD
CY2021Q1 pcrx Contingent Consideration Noncurrent
ContingentConsiderationNoncurrent
12355000 USD
CY2020Q4 pcrx Contingent Consideration Noncurrent
ContingentConsiderationNoncurrent
13610000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5288000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3832000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
636731000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
654825000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43957510 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43957510 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43636929 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43636929 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
44000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
44000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
894108000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
873201000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-243506000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-253875000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
172000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
318000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
650818000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
619688000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1287549000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1274513000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
119027000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105684000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
31349000 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
29732000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15879000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15819000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48522000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44780000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1967000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1967000 USD
CY2021Q1 pcrx Acquisition Related Gain Loss Product Discontinuation Costs And Other Net
AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
-1873000 USD
CY2020Q1 pcrx Acquisition Related Gain Loss Product Discontinuation Costs And Other Net
AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
3708000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
99590000 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
88590000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
19437000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17094000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
415000 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1589000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
6971000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
6022000 USD
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45966000 shares
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-157000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4104000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6713000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8537000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12724000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8557000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2355000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
398000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
10369000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8159000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43833000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42032000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42785000 shares
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
10369000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8159000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-150000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1368000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-146000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1368000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10223000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6791000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
619688000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10797000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10110000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-146000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
10369000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
650818000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
354944000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3455000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8847000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1368000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8159000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
374037000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
10369000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8159000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1746000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4851000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4821000 USD
CY2021Q1 pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
651000 USD
CY2020Q1 pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
439000 USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5657000 USD
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3594000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
11000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-22000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
10110000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8847000 USD
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1127000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-3874000 USD
CY2021Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
155000 USD
CY2020Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
3971000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-462000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8542000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-43000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1370000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-254000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3674000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1351000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2868000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-18027000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-24700000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1701000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1173000 USD
CY2021Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
0 USD
CY2020Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
264000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12081000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6208000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13073000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6724000 USD
CY2021Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
186653000 USD
CY2020Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
72610000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
145282000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
50768000 USD
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1220000 USD
CY2020Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55664000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28566000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10325000 USD
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3455000 USD
CY2021Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
CY2020Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
4736000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10325000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1281000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33258000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23639000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99957000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78228000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66699000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54589000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
1686000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7033000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2595000 USD
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
31697000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
26886000 USD
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10035000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
16266000 USD
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
22874000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
21498000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
64606000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
64650000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
226039000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
215048000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
81217000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78360000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
144822000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
136688000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
2900000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
2900000 USD
CY2021Q1 pcrx Foreign Property Plantand Equipment Net
ForeignPropertyPlantandEquipmentNet
67800000 USD
CY2020Q4 pcrx Foreign Property Plantand Equipment Net
ForeignPropertyPlantandEquipmentNet
67500000 USD
CY2021Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
2000000.0 USD
CY2020Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
2000000.0 USD
CY2021Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P9Y4M24D
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2922000 USD
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1564000 USD
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
478000 USD
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
448000 USD
CY2021Q1 us-gaap Lease Cost
LeaseCost
3400000 USD
CY2020Q1 us-gaap Lease Cost
LeaseCost
2012000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
4600000 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2759000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
174000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y11M12D
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y2M23D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0689
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0755
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
8059000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10423000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10697000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10980000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11271000 USD
CY2021Q1 pcrx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
50802000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
102232000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
27063000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
75169000 USD
CY2021Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2021Q1 us-gaap Goodwill
Goodwill
99500000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
99500000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000.0 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000.0 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5900000 USD
CY2021Q1 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period1
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1
7900000 USD
CY2021Q1 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period2
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2
2200000 USD
CY2021Q1 pcrx Settlement Period Convertible Debt Conversion Request
SettlementPeriodConvertibleDebtConversionRequest
P40D
CY2021Q1 pcrx Deferred Tax Expense Associated To The Equity Component Of Convertible Debt
DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt
20500000 USD
CY2021Q1 pcrx Amortization Period Of Transaction Costs Attributable To Liability Component Of Convertible Debt
AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt
P5Y
CY2021Q1 pcrx Transaction Costs Attributable To The Equity Component Of Convertible Debt
TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt
2700000 USD
CY2021Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1705000 USD
CY2020Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2049000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
651000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
439000 USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5657000 USD
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3594000 USD
CY2021Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1042000 USD
CY2020Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
60000 USD
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
6971000 USD
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
6022000 USD
CY2021Q1 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0670
CY2020Q1 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0781
CY2021Q1 us-gaap Share Price
SharePrice
70.09
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
558215000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
155000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
35000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
558335000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
516845000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
350000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
31000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
517164000 USD
CY2021Q1 us-gaap Interest Receivable
InterestReceivable
800000 USD
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
1600000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10110000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8847000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
10110000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8847000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6235118 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
45.98
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
43500 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
65.49
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
317259 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
34.03
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
96265 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
45.29
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6616 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
71.11
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5858478 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.76
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.86
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
CY2021Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0 shares
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
10369000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8159000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43833000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42032000 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
152000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45966000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42785000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
892000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5385000 shares
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
15933000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
9821000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-3209000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1264000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12724000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8557000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000 USD

Files In Submission

Name View Source Status
0001396814-21-000031-index-headers.html Edgar Link pending
0001396814-21-000031-index.html Edgar Link pending
0001396814-21-000031.txt Edgar Link pending
0001396814-21-000031-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pcrx-20210331.htm Edgar Link pending
pcrx-20210331.xsd Edgar Link pending
pcrx-20210331_cal.xml Edgar Link unprocessable
pcrx-20210331_def.xml Edgar Link unprocessable
pcrx-20210331_g1.jpg Edgar Link pending
pcrx-20210331_g2.jpg Edgar Link pending
pcrx-20210331_htm.xml Edgar Link completed
pcrx-20210331_lab.xml Edgar Link unprocessable
pcrx-20210331_pre.xml Edgar Link unprocessable
pcrx-3312021xex101.htm Edgar Link pending
pcrx-3312021xexhibit321.htm Edgar Link pending
pcrx10-qq12021ex311.htm Edgar Link pending
pcrx10-qq12021ex312.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending